(c) 2020 PillSync.com

zolmitriptan 25 MG Disintegrating Oral Tablet

1 INDICATIONS AND USAGE Zolmitriptan orally disintegrating tablets are a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults ( 1 ) Limitations of Use: Use only after a clear diagnosis of migraine has been established ( 1 ) Not indicated for the prophylactic therapy of migraine ( 1 ) Not indicated for the treatment of cluster headache ( 1 ) Zolmitriptan orally disintegrating tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use Only use zolmitriptan if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks. Zolmitriptan orally disintegrating tablets are not indicated for the prevention of migraine attacks. Safety and effectiveness of zolmitriptan have not been established for cluster headache.

Zydus Pharmaceuticals (USA) Inc.


COVID-19 Cases Near You

Bitcoin Booming in Financial Crisis

Lowest Fees to Buy Crypto

Go PRO to remove this ad
3 months ago ROUND WHITE 715 zolmitriptan 25 MG Disintegrating Oral Tablet

ROUND WHITE 715

Related Pills

Simvastatin 40 MG Oral Tablet

Teva Pharmaceuticals USA Inc

Celecoxib celecoxib 200 MG Oral Capsule

Mylan Pharmaceuticals Inc.

celecoxib capsule

mylan pharmaceuticals inc.

warfarin sodium tablet

teva pharmaceuticals usa, inc.

warfarin sodium tablet

teva pharmaceuticals usa, inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site